Precision Therapeutics Announces Results of Special Meeting of Stockholders

    NEXT STORY
    Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
    PREV STORY
    CytomX Therapeutics Announces Transition of Chief Financial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update

    Key updates Runway into the second half of 2019: cash of €48.0 million at ...

    author_avatar
    NASDAQ Market News

    Stemline Therapeutics to Present at Upcoming Investor Conferences

    NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne

    DUBLIN, Ireland and BOSTON, March 27, 2017 (GLOBE NEWSWIRE) -- Allergan plc, (NYSE:AGN), a ...

    author_avatar
    NASDAQ Market News